1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Australia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Australia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "Australia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Australia In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the Australia In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Australia In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
2.2 In Vitro Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 In Vitro Diagnostics Market, Australia 29
3.1 In Vitro Diagnostics Market, Australia, Revenue ($m), 2007-2021 29
3.2 In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2014 31
3.3 In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2014 32
3.4 In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), 2007-2021 34
3.5 In Vitro Diagnostics Market, Australia, Revenue ($m), 2007-2014 36
3.6 In Vitro Diagnostics Market, Australia, Revenue ($m), 2014-2021 38
3.7 In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), 2014 40
4 Clinical Chemistry Market, Australia 42
4.1 Clinical Chemistry Market, Australia, Revenue Mix ($m), 2014 42
4.2 Clinical Chemistry Market, Australia, Segment Contribution (%), 2014 43
4.3 Clinical Chemistry Market, Australia, Revenue ($m), 2007-2014 45
4.4 Clinical Chemistry Market, Australia, Revenue ($m), 2014-2021 47
4.4.1 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2007-2014 49
4.4.2 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2007-2014 51
4.4.3 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2007-2014 53
4.4.4 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2014-2021 55
4.4.5 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2014-2021 57
4.4.6 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2014-2021 59
4.5 Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), 2013-2014 61
4.6 Clinical Chemistry Market, Australia, Company Share by Revenue ($m), 2014 62
5 Genetic Testing Market, Australia 64
5.1 Genetic Testing Market, Australia, Revenue Mix ($m), 2014 64
5.2 Genetic Testing Market, Australia, Segment Contribution (%), 2014 65
5.3 Genetic Testing Market, Australia, Revenue ($m), 2007-2014 66
5.4 Genetic Testing Market, Australia, Revenue ($m), 2014-2021 68
5.5 Genetic Testing Market, Australia, Distribution Share by Revenue ($m), 2013-2014 70
5.6 Genetic Testing Market, Australia, Company Share by Revenue ($m), 2014 71
6 Haematology Market, Australia 73
6.1 Haematology Market, Australia, Revenue Mix ($m), 2014 73
6.2 Haematology Market, Australia, Segment Contribution (%), 2014 74
6.3 Haematology Market, Australia, Revenue ($m), 2007-2014 76
6.4 Haematology Market, Australia, Revenue ($m), 2014-2021 78
6.4.1 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2007-2014 80
6.4.2 Haematology Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2007-2014 82
6.4.3 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2007-2014 84
6.4.4 Haemostasis Market, Australia, Revenue ($m), by Segment, 2007-2014 86
6.4.5 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2007-2014 88
6.4.6 Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2014-2021 90
6.4.7 Haematology Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2014-2021 92
6.4.8 Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2014-2021 94
6.4.9 Haemostasis Market, Australia, Revenue ($m), by Segment, 2014-2021 96
6.4.10 Immunohaematology Market, Australia, Revenue ($m), by Segment, 2014-2021 98
6.5 Haematology Market, Australia, Distribution Share by Revenue ($m), 2013-2014 100
6.6 Haematology Market, Australia, Company Share by Revenue ($m), 2014 101
7 Histology And Cytology Market, Australia 103
7.1 Histology And Cytology Market, Australia, Revenue Mix ($m), 2014 103
7.2 Histology And Cytology Market, Australia, Segment Contribution (%), 2014 104
7.3 Histology And Cytology Market, Australia, Revenue ($m), 2007-2014 105
7.4 Histology And Cytology Market, Australia, Revenue ($m), 2014-2021 107
7.5 Histology And Cytology Market, Australia, Distribution Share by Revenue ($m), 2013-2014 109
7.6 Histology And Cytology Market, Australia, Company Share by Revenue ($m), 2014 110
8 Immuno Chemistry Market, Australia 112
8.1 Immuno Chemistry Market, Australia, Revenue Mix ($m), 2014 112
8.2 Immuno Chemistry Market, Australia, Segment Contribution (%), 2014 113
8.3 Immuno Chemistry Market, Australia, Revenue ($m), 2007-2014 115
8.4 Immuno Chemistry Market, Australia, Revenue ($m), 2014-2021 117
8.4.1 Anemia Tests Market, Australia, Revenue ($m), by Segment, 2007-2014 119
8.4.2 Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2007-2014 121
8.4.3 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2007-2014 123
8.4.4 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2007-2014 125
8.4.5 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2007-2014 127
8.4.6 Immunochemistry Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2007-2014 129
8.4.7 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2007-2014 131
8.4.8 Anemia Tests Market, Australia, Revenue ($m), by Segment, 2014-2021 133
8.4.9 Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2014-2021 135
8.4.10 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2014-2021 137
8.4.11 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2014-2021 139
8.4.12 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2014-2021 141
8.4.13 Immunochemistry Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2014-2021 143
8.4.14 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2014-2021 145
8.5 Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), 2013-2014 147
8.6 Immuno Chemistry Market, Australia, Company Share by Revenue ($m), 2014 148
9 Infectious Diagnostics Market, Australia 150
9.1 Infectious Diagnostics Market, Australia, Revenue Mix ($m), 2014 150
9.2 Infectious Diagnostics Market, Australia, Segment Contribution (%), 2014 151
9.3 Infectious Diagnostics Market, Australia, Revenue ($m), 2007-2014 153
9.4 Infectious Diagnostics Market, Australia, Revenue ($m), 2014-2021 155
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2007-2014 157
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), by Segment, 2014-2021 159
9.5 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 161
9.6 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2014 162
10 Microbiology Culture Market, Australia 164
10.1 Microbiology Culture Market, Australia, Revenue Mix ($m), 2014 164
10.2 Microbiology Culture Market, Australia, Segment Contribution (%), 2014 165
10.3 Microbiology Culture Market, Australia, Revenue ($m), 2007-2014 167
10.4 Microbiology Culture Market, Australia, Revenue ($m), 2014-2021 169
10.4.1 Microbiology Analyzers Market, Australia, Revenue ($m), by Segment, 2007-2014 171
10.4.2 Microbiology Analyzers Market, Australia, Revenue ($m), by Segment, 2014-2021 173
10.5 Microbiology Culture Market, Australia, Distribution Share by Revenue ($m), 2013-2014 175
10.6 Microbiology Culture Market, Australia, Company Share by Revenue ($m), 2014 176
11 Overview of Key Companies in Australia, In Vitro Diagnostics Market 178
11.1 Siemens Healthcare 178
11.1.1 Company Overview 178
11.2 Abbott Laboratories 178
11.2.1 Company Overview 178
11.3 F. Hoffmann-La Roche Ltd. 178
11.3.1 Company Overview 178
11.4 Danaher Corporation 179
11.4.1 Company Overview 179
11.5 bioMerieux S.A. 179
11.5.1 Company Overview 179
11.6 Becton, Dickinson and Company 179
11.6.1 Company Overview 179
11.7 Bio-Rad Laboratories, Inc. 180
11.7.1 Company Overview 180
11.8 Sysmex Corporation 180
11.8.1 Company Overview 180
11.9 Qiagen N.V. 180
11.9.1 Company Overview 180
11.10 Horiba, Ltd. 181
11.10.1 Company Overview 181
12 In Vitro Diagnostics Market Pipeline Products 182
13 Financial Deals Landscape 188
13.1 Acquisition 188
13.1.1 STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 188
13.2 Equity Offerings 190
13.2.1 Medibio Raises USD2.2 Million in Private Placement of Shares 190
13.2.2 NuSep to Raise Funds through Share Purchase Plan 191
13.2.3 Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 192
13.2.4 Reproductive Health Science Raises USD1 Million in Private Placement of Shares 193
13.2.5 Genetic Technologies to Raise USD20 Million in Private Placement of Shares 194
13.2.6 Human Genetic Signatures Raises USD6.5 Million in IPO 195
13.2.7 Proteomics Files Prospectus for IPO for USD5.2 Million 196
13.3 Partnerships 197
13.3.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 197
13.3.2 University of Melbourne Enters into Licensing Agreement with Transgenomic 198
13.3.3 Scienion Partners with Axxin 199
13.3.4 Seegene Enters into Co-Development Agreement with BD Life Sciences 200
13.3.5 MdxHealth Enters into Licensing Agreement with Erasmus MC 201
13.3.6 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 202
13.3.7 Sigma-Aldrich Enters into Distribution Agreement with LGC 203
13.3.8 OvaGene Oncology Enters into Agreement with Etta Healthcare 204
13.3.9 InTouch Health Enters into Agreement with iSchemaView 205
13.3.10 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 206
13.3.11 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 207
13.3.12 NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 208
13.3.13 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 209
13.3.14 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 210
13.3.15 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 211
13.3.16 AngioDynamics Enters into Licensing Agreement with EmboMedics 212
13.3.17 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 213
13.3.18 Biocartis Enters into Licensing and Development Agreement with Microbiome 214
13.3.19 CBScientific Enters into Distribution Agreement with UTest 215
13.3.20 Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 216
13.3.21 Event Cardio Enters into Licensing Agreement with MedPac Asia Pacific 217
13.3.22 GeneThera Enters into Co-Development Agreement with Hudson Robotics 218
13.3.23 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 219
13.3.24 Genomic Vision Extends Agreement with Quest Diagnostics 220
13.3.25 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 221
13.3.26 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 223
13.3.27 BioMerieux Enters into Licensing Agreement with Astute Medical 224
13.3.28 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 225
13.3.29 NoemaLife Enters into Distribution Agreement with Horiba Medical 226
13.3.30 Victorian Clinical Genetics Enters into Agreement with Illumina to Develop NIPT 227
13.3.31 Clinical Genomics Enters into Licensing Agreement with CSIRO 228
13.3.32 Nicox Enters into Licensing Agreement with OptiMed for AdenoPlus and Xailin 229
14 Recent Developments 230
14.1 Corporate Communications 230
14.1.1 Sep 29, 2015: PolyNovo awarded BARDA contract for clinical burn trials 230
14.1.2 Jul 21, 2015: Cellmid Appoints Dr Fintan Walton As Non-Executive Director 231
14.1.3 Jun 15, 2015: Genetic Technologies: Appointment of Chief Financial Officer 231
14.1.4 Jun 12, 2015: Genetic Technologies: Appointment of Executive Director 231
14.1.5 Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality 232
14.1.6 May 26, 2015: Appointment And Resignation Of Directors 233
14.1.7 Apr 23, 2015: Gordon Naylor to lead CSL's Global Influenza Vaccine Business 233
14.1.8 Apr 14, 2015: Medibio appoints highly distinguished US medical expert, Franklyn G. Prendergast, M.D., Ph.D., to its Physician Advisory Board 234
14.1.9 Mar 31, 2015: Cellmid Announces Company Secretary Appointment And Resignations 235
14.1.10 Feb 26, 2015: Genetic Technologies Appoints Eutillio Buccilli as Chief Executive Officer 235
14.1.11 Feb 04, 2015: Sienna Appoints Dr Cliff Holloway As Interim CEO 236
14.1.12 Nov 11, 2014: Afaxys Announces Wider National Availability of ella Emergency Contraceptive 237
14.1.13 Nov 11, 2014: Oculus Innovative Sciences Commercializes Microcyn-Based Solution and Hydrogel for Treatment of Mild-to-Moderate Acne in Europe 237
14.1.14 Oct 22, 2014: AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 238
14.1.15 Oct 08, 2014: Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative Pain 238
14.2 Financial Announcements 239
14.2.1 Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 239
14.2.2 Jul 09, 2015: Cellmid Revenue Guidance Upgrade 240
14.2.3 Apr 16, 2015: Pericoach Clinical Trial Recruitment Commences 240
14.2.4 Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement 243
14.2.5 Feb 11, 2015: CSL delivers solid first half Strong investments for future growth 245
14.2.6 Jan 19, 2015: Australian comprehensive cancer center switches to Elekta's MOSAIQ Oncology Information System 245
14.2.7 Oct 22, 2014: iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 246
14.2.8 Oct 08, 2014: Achillion To Present Preclinical Profile Of ACH-3422 At The American Association For The Study Of Liver Diseases (AASLD) Annual Meeting 247
14.3 Legal And Regulatory 248
14.3.1 Nov 03, 2014: Agilent Technologies Granted Dismissal in Patent Infringement Suit Brought by Genetic Technologies 248
14.4 Other Significant Developments 249
14.4.1 Sep 02, 2015: Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 249
14.4.2 Aug 25, 2015: SYGNIS signs non-exclusive distribution agreement for Australia with GeneWorks 249
14.4.3 Aug 13, 2015: Genetic Signatures expands into multiple European countries for its infectious disease detection products 250
14.4.4 Jul 06, 2015: Microarray Instrument from Arrayjet amplifies production at Reproductive Health Science 251
14.4.5 May 14, 2015: MyHealthTest Wins 1$m Grant 251
14.4.6 Feb 28, 2015: Sienna Cancer Diagnostics: A$800,000 Grant For Commercialisation 252
14.4.7 Dec 04, 2014: Global recognition for developing eye tests to diagnose diabetes-related nerve damage 252
14.4.8 Oct 29, 2014: Starpharma Receives $4.2 million RandD Tax Incentive Refund 253
14.5 Product News 253
14.5.1 Apr 14, 2015: Luminex Shows Support for Anteo MixandGo Activation Kit for Multiplex Microspheres 253
14.5.2 Feb 19, 2015: Biomarker discovery offers clearer prognosis for bowel and rectal cancer patients 253
14.5.3 Oct 29, 2014: Blood Test Developed To Diagnose Early Onset Alzheimer's Disease 254
14.6 Strategy And Business Planning 255
14.6.1 Jan 27, 2015: Otsuka Australia Pharmaceutical Opens in Australia 255
14.6.2 Nov 26, 2014: Sysmex Establishes New Subsidiary in Australia - Aiming to Further Increase the Company's Presence in the Asia-Pacific Region 255
14.6.3 Oct 08, 2014: CSL announces major manufacturing expansion in Melbourne 256
15 Appendix 257
15.1 Research Methodology 258
15.1.1 Coverage 258
15.1.2 Secondary Research 258
15.1.3 Primary Research 258
15.1.4 Company Share Analysis 259
15.1.5 Distribution Share Analysis 259
15.2 GlobalData Consulting 259
15.3 Contact Us 259
15.4 Disclaimer 260

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2007-2021 30
Table 2: In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2014 33
Table 3: In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Table 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 5: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 6: In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 41
Table 7: Clinical Chemistry Market, Australia, Segment Contribution (%), 2014 44
Table 8: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 9: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 10: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 11: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 12: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 13: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 14: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 15: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 16: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 17: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 63
Table 18: Genetic Testing Market, Australia, Segment Contribution (%), 2014 65
Table 19: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 67
Table 20: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 21: Genetic Testing Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 70
Table 22: Genetic Testing Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 72
Table 23: Haematology Market, Australia, Segment Contribution (%), 2014 75
Table 24: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 77
Table 25: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Table 26: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 27: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 28: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 29: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 30: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 31: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 32: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 33: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 34: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 35: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 36: Haematology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 100
Table 37: Haematology Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 102
Table 38: Histology And Cytology Market, Australia, Segment Contribution (%), 2014 104
Table 39: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 106
Table 40: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Table 41: Histology And Cytology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 109
Table 42: Histology And Cytology Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 111
Table 43: Immuno Chemistry Market, Australia, Segment Contribution (%), 2014 114
Table 44: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 116
Table 45: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 118
Table 46: Anemia Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 120
Table 47: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 122
Table 48: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 124
Table 49: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 126
Table 50: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 128
Table 51: Immunochemistry Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 130
Table 52: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 132
Table 53: Anemia Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Table 54: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 55: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 56: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Table 57: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Table 58: Immunochemistry Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Table 59: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Table 60: Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 147
Table 61: Immuno Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 149
Table 62: Infectious Diagnostics Market, Australia, Segment Contribution (%), 2014 152
Table 63: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 154
Table 64: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Table 65: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 158
Table 66: Infectious Diagnostics Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Table 67: Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 161
Table 68: Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 163
Table 69: Microbiology Culture Market, Australia, Segment Contribution (%), 2014 166
Table 70: Microbiology Culture Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 168
Table 71: Microbiology Culture Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Table 72: Microbiology Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 172
Table 73: Microbiology Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Table 74: Microbiology Culture Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 175
Table 75: Microbiology Culture Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 177
Table 76: In Vitro Diagnostics Market Pipeline Products 182
Table 77: STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 188
Table 78: Medibio Raises USD2.2 Million in Private Placement of Shares 190
Table 79: NuSep to Raise Funds through Share Purchase Plan 191
Table 80: Cellmid Raises USD2.4 Million in First Tranche of Private Placement of Shares 192
Table 81: Reproductive Health Science Raises USD1 Million in Private Placement of Shares 193
Table 82: Genetic Technologies to Raise USD20 Million in Private Placement of Shares 194
Table 83: Human Genetic Signatures Raises USD6.5 Million in IPO 195
Table 84: Proteomics Files Prospectus for IPO for USD5.2 Million 196
Table 85: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 197
Table 86: University of Melbourne Enters into Licensing Agreement with Transgenomic 198
Table 87: Scienion Partners with Axxin 199
Table 88: Seegene Enters into Co-Development Agreement with BD Life Sciences 200
Table 89: MdxHealth Enters into Licensing Agreement with Erasmus MC 201
Table 90: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 202
Table 91: Sigma-Aldrich Enters into Distribution Agreement with LGC 203
Table 92: OvaGene Oncology Enters into Agreement with Etta Healthcare 204
Table 93: InTouch Health Enters into Agreement with iSchemaView 205
Table 94: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 206
Table 95: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 207
Table 96: NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 208
Table 97: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 209
Table 98: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 210
Table 99: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 211
Table 100: AngioDynamics Enters into Licensing Agreement with EmboMedics 212
Table 101: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 213
Table 102: Biocartis Enters into Licensing and Development Agreement with Microbiome 214
Table 103: CBScientific Enters into Distribution Agreement with UTest 215
Table 104: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 216
Table 105: Event Cardio Enters into Licensing Agreement with MedPac Asia Pacific 217
Table 106: GeneThera Enters into Co-Development Agreement with Hudson Robotics 218
Table 107: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 219
Table 108: Genomic Vision Extends Agreement with Quest Diagnostics 220
Table 109: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 221
Table 110: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 223
Table 111: BioMerieux Enters into Licensing Agreement with Astute Medical 224
Table 112: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 225
Table 113: NoemaLife Enters into Distribution Agreement with Horiba Medical 226
Table 114: Victorian Clinical Genetics Enters into Agreement with Illumina to Develop NIPT 227
Table 115: Clinical Genomics Enters into Licensing Agreement with CSIRO 228
Table 116: Nicox Enters into Licensing Agreement with OptiMed for AdenoPlus and Xailin 229

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2007-2021 29
Figure 2: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2014 31
Figure 3: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2014 32
Figure 4: In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Figure 5: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 6: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 7: In Vitro Diagnostics Market, Australia, Company Share (%) 2014 40
Figure 8: Clinical Chemistry Market, Australia, Revenue Mix ($m), 2014 42
Figure 9: Clinical Chemistry Market, Australia, Segment Contribution (%), 2014 43
Figure 10: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 11: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 12: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 13: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 14: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 15: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 16: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 17: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 18: Clinical Chemistry Market, Australia, Company Share (%) 2014 62
Figure 19: Genetic Testing Market, Australia, Revenue Mix ($m), 2014 64
Figure 20: Genetic Testing Market, Australia, Segment Contribution (%), 2014 65
Figure 21: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 66
Figure 22: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 23: Genetic Testing Market, Australia, Company Share (%) 2014 71
Figure 24: Haematology Market, Australia, Revenue Mix ($m), 2014 73
Figure 25: Haematology Market, Australia, Segment Contribution (%), 2014 74
Figure 26: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 76
Figure 27: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Figure 28: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 29: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 30: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 31: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 32: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 33: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 34: Haematology Rapid Tests and POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 35: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 36: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 37: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 38: Haematology Market, Australia, Company Share (%) 2014 101
Figure 39: Histology And Cytology Market, Australia, Revenue Mix ($m), 2014 103
Figure 40: Histology And Cytology Market, Australia, Segment Contribution (%), 2014 104
Figure 41: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 105
Figure 42: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Figure 43: Histology And Cytology Market, Australia, Company Share (%) 2014 110
Figure 44: Immuno Chemistry Market, Australia, Revenue Mix ($m), 2014 112
Figure 45: Immuno Chemistry Market, Australia, Segment Contribution (%), 2014 113
Figure 46: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 115
Figure 47: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 117
Figure 48: Anemia Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 119
Figure 49: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 121
Figure 50: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 123
Figure 51: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 125
Figure 52: Immunochemistry Analyzers Market, Australia, R

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.